Cargando…

Oral Treatment with RD2RD2 Impedes Development of Motoric Phenotype and Delays Symptom Onset in SOD1(G93A) Transgenic Mice

Neuroinflammation is a pathological hallmark of several neurodegenerative disorders and plays a key role in the pathogenesis of amyotrophic lateral sclerosis (ALS). It has been implicated as driver of disease progression and is observed in ALS patients, as well as in the transgenic SOD1(G93A) mouse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Post, Julia, Schaffrath, Anja, Gering, Ian, Hartwig, Sonja, Lehr, Stefan, Shah, N. Jon, Langen, Karl-Josef, Willbold, Dieter, Kutzsche, Janine, Willuweit, Antje
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269060/ https://www.ncbi.nlm.nih.gov/pubmed/34209129 http://dx.doi.org/10.3390/ijms22137066

Ejemplares similares

Oral Treatment with d-RD2RD2 Impedes Early Disease Mechanisms in SOD1*G93A Transgenic Mice but Does Not Prolong Survival
por: Wintz, Katharina, et al.
Publicado: (2023)

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
por: Schemmert, Sarah, et al.
Publicado: (2018)

A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model
por: Post, Julia, et al.
Publicado: (2021)

In Vitro and In Vivo Efficacies of the Linear and the Cyclic Version of an All-d-Enantiomeric Peptide Developed for the Treatment of Alzheimer’s Disease
por: Schemmert, Sarah, et al.
Publicado: (2021)

The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathology
por: van Groen, Thomas, et al.
Publicado: (2017)

Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers
por: Elfgen, Anne, et al.
Publicado: (2019)

Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs – A model of sporadic Alzheimer’s disease
por: Kutzsche, Janine, et al.
Publicado: (2023)

In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer’s Disease
por: Schartmann, Elena, et al.
Publicado: (2018)

Sex-Related Motor Deficits in the Tau-P301L Mouse Model
por: Camargo, Luana Cristina, et al.
Publicado: (2021)

Comprehensive Characterization of the Pyroglutamate Amyloid-β Induced Motor Neurodegenerative Phenotype of TBA2.1 Mice
por: Dunkelmann, Tina, et al.
Publicado: (2018)

PEAβ Triggers Cognitive Decline and Amyloid Burden in a Novel Mouse Model of Alzheimer’s Disease
por: Camargo, Luana Cristina, et al.
Publicado: (2021)

Preclinical Pharmacokinetic Studies of the Tritium Labelled D-Enantiomeric Peptide D3 Developed for the Treatment of Alzheimer´s Disease
por: Jiang, Nan, et al.
Publicado: (2015)

Do We Need Anti-Prionic Compounds to Treat Alzheimer’s Disease?
por: Willbold, Dieter, et al.
Publicado: (2019)

Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer’s Disease
por: Kutzsche, Janine, et al.
Publicado: (2017)

Agenda for the 93rd meeting of the Large Hadron Collider Committee
por: Tsesmelis, Emmanuel
Publicado: (2008)

93rd Meeting of the SPSC on 29-30 September 2009
por: CERN. Geneva. SPS and PS Experiments Committee, et al.
Publicado: (2009)

Safety and pharmacokinetics of the orally available antiprionic compound PRI‐002: A single and multiple ascending dose phase I study
por: Kutzsche, Janine, et al.
Publicado: (2020)

Addendum to the RD-28 status report (CERN/DRDC/93-34)
por: CERN. Geneva. Detector Research and Development Committee
Publicado: (1993)

93rd IAU Symposium on Fundamental Problems in the Theory of Stellar Evolution
por: Lamb, Donald Q, et al.
Publicado: (1981)

Agenda for the 93rd Meeting of the Research Board on 1 June 1989
por: CERN. Geneva. Research Board
Publicado: (1989)

Memorandum for the 93rd Meeting of the Research Board on 1 June 1989
por: CERN. Geneva. Research Board, et al.
Publicado: (1989)

Minutes of the 93rd Meeting of the SPSC on 29-30 september 2009
por: CERN. Geneva. SPS and PS Experiments Committee, et al.
Publicado: (2009)

Abstract Book - 93rd National Congress of the Italian Society of Orthopaedics and Traumatology
Publicado: (2008)

Genetic Biomarkers for ALS Disease in Transgenic SOD1(G93A) Mice
por: Calvo, Ana C., et al.
Publicado: (2012)

Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography
por: Willuweit, Antje, et al.
Publicado: (2021)

3rd National Seminar on Physics and Technology of Particle Accelerators and Applications : PATPAA '93
Publicado: (1993)

Minutes of the 93rd meeting of the Research Board held on Thursday 1 June 1989
por: CERN. Geneva. Research Board, et al.
Publicado: (1989)

93rd Colloquium on Cataclysmic Variables. Recent Multi-Frequency Observations and Theoretical Developments
por: Drechsel, H, et al.
Publicado: (1987)

Omics Profiles of Non-transgenic Scion Grafted on Transgenic RdDM Rootstock
por: Kodama, Hiroaki, et al.
Publicado: (2022)

Decisions of the 93rd meeting of the Nuclear Physics Research Committee on October 28th, 1970
por: CERN. Geneva. Nuclear Physics Research Committee
Publicado: (1970)

Agenda for the 93rd Meeting of the SPSC on Tuesday 29 september and Wednesday 30 September 2009
por: CERN. Geneva. SPS and PS Experiments Committee, et al.
Publicado: (2009)

Minutes of the 93rd LHCC meeting held on Wednesday and Thursday 7 and 8 May 2008
por: CERN. Geneva. The LHC experiments Committee
Publicado: (2008)

Assessing the therapeutic impact of resveratrol in ALS SOD1-G93A mice with electrical impedance myography
por: Nagy, Janice A., et al.
Publicado: (2022)

Distribution Features and Potential Effects of Serotonin in the Cerebrum of SOD1 G93A Transgenic Mice
por: He, Pei, et al.
Publicado: (2022)

Repaglinide Induces ATF6 Processing and Neuroprotection in Transgenic SOD1G93A Mice
por: Gonzalo-Gobernado, Rafael, et al.
Publicado: (2023)

3rd RD48 status report
por: Lindström, G, et al.
Publicado: (1999)

Agenda for the 3rd ISC meeting on 2nd and 3rd March 1992
por: CERN. Geneva. ISOLDE Experiments Committee
Publicado: (1992)

3rd Conference on Functional Analysis
por: Bierstedt, Klaus-Dieter, et al.
Publicado: (1984)

Gamisoyo-San Ameliorates Neuroinflammation in the Spinal Cord of hSOD1(G93A) Transgenic Mice
por: Cai, MuDan, et al.
Publicado: (2018)

The Involvement of RAGE and Its Ligands during Progression of ALS in SOD1 G93A Transgenic Mice
por: Nowicka, Natalia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ulhkj5vq9c7bal74ae0h9ohs5l